http://www.reportbuyer.com/rss.htmlAcquire Obesity market intelligence. Information products include Drug Discoveries, Anti-Obesity Treatments and Future Forecasts.  en-gbReportbuyerservice@reportbuyer.comenquiries@redwiredesign.comhttp://www.reportbuyer.com/pharma_healthcare/therapeutic/obesity/forecast_insight_antihypertensives.htmlFollowing the patent expiries of ARBs Datamonitor expects antihypertensives sales in the seven major markets to record sales of $29. 5 billion in 2018, a drop of over $6 billion compared to 2008. With no promising novel pipeline agents, pharmaceutical companies have little choice but to adopt line extension life cycle management strategies introducing a number of new fixed dose combinations. 151018a9638569bbd1e9369c5ae60f80Tue, 07 Jul 2009 12:00:00 GBTherapeutic/Obesityhttp://www.reportbuyer.com/pharma_healthcare/therapeutic/obesity/obesity_market_forecast.htmlThe obesity market is easily characterized as attractive, featuring a booming patient potential needing long term therapy, but repeated product withdrawals and failed pipeline candidates highlight the reality of increasingly cautious regulatory bodies, reluctant payers, and a clinical community that puts more stock in diet and exercise: $513. 7m sales in 2008 fall far short of analyst predictions. Reasons to Purchase Understand why predictions for this market have been repeatedly over-stated Qualify market expectations against the practicalities of targeting this unyielding market Assess the qualities of marketed and pipeline products and their commercial handling to determine their realistic prospects . 42b971987f2313bb2812cd8f8de98656Tue, 07 Jul 2009 12:00:00 GBTherapeutic/Obesityhttp://www.reportbuyer.com/pharma_healthcare/therapeutic/obesity/booming_global_obesity_drug_market.html"Booming Global Obesity Drug Market" our latest research on the obesity market states that the prevalence of obesity is increasing globally at alarming rates. Obesity drugs market has shown a radical growth in recent times but in contrast the market for weight loss drugs has failed to match this growth. By 2012 it's expected that more than two billion people will be overweight and 600 Million will be obese representing immense opportunities for both the markets. 143a14b1f2c604132f6c900ebd57ca5bFri, 12 Dec 2008 12:00:00 GBTherapeutic/Obesityhttp://www.reportbuyer.com/pharma_healthcare/therapeutic/obesity/obesity_drug_markets_us_eu.htmlObesity Drug Markets in the US and EU Analysis of product pipelines and competitive environment Business Intelligence for the Pharmaceutical Industry Business Insights' portfolio of healthcare management reports is designed to help you make well informed and timely business decisions. We understand the problems facing today's pharmaceutical and healthcare executives when trying to drive your business forward, and appreciate the importance of accurate, up-to-date, incisive product, market and company analysis. We help you to crystallize your business decisions. 2ec3209df1b1775bc7e228b3ce3a4f24Tue, 01 Jul 2008 12:00:00 GBTherapeutic/Obesityhttp://www.reportbuyer.com/pharma_healthcare/therapeutic/obesity/obesity_drug_discoveries_future_holds.htmlThis chapter of New Drug Futures evaluates, compares and contrasts the prospects for the compounds that will revolutionise the pharmaceutical industry over the next 5 years and beyond in the anti-infective sector. The report includes unique sales forecasts by major product. The full 400-page report, evaluates, compares and contrasts the prospects for the compounds that will revolutionise the pharmaceutical industry over the next 5 years and beyond. 3739efcd5259e2218cf0991bd5dda6afWed, 22 Aug 2007 12:00:00 GBTherapeutic/Obesityhttp://www.reportbuyer.com/pharma_healthcare/therapeutic/obesity/obesity_drug_discoveries_future_holds_obesity_tracker.htmlObesity has reached epidemic proportions worldwide. With 2005 estimates of approximately 1. 6 billion adults (aged 15 years and over) overweight and at least 400 million adults obese, the World Health Organization predicts that by 2015, approximately 2. 089319a0923171c9374a844da1dd6884Wed, 22 Aug 2007 12:00:00 GBTherapeutic/Obesityhttp://www.reportbuyer.com/pharma_healthcare/therapeutic/obesity/anti_obesity_treatments_2007_2012_blockbuster_target_market.htmlPlease Note: Reports are sold based on the user licenses indicated. The reports will be accessible in Flash format via an online reading room on the publisher website, allowing viewing and printing capabilities only. Within one to two business days after placing the order,the client will receive an email with information on accessing their purchase. c7a27283499184af3c99612666f60346Fri, 13 Jul 2007 12:00:00 GBTherapeutic/Obesityhttp://www.reportbuyer.com/pharma_healthcare/therapeutic/obesity/childhood_obesity.htmlWith more than 9 million overweight American children and adolescents---triple the number identified in 1980---healthcare providers must react now to counteract the related health and social consequences that often continue into adulthood. In this special report, "Childhood Obesity: Truths, Trends & Program Design," sponsored by the Healthcare Intelligence Network (HIN), expert speakers provide background on this growing epidemic. You'll also get case studies on programs launched by healthcare payors and providers to address childhood obesity. 56581884029f6be74b35ee6693080034Sat, 01 Jan 2005 12:00:00 GBTherapeutic/Obesity